Valuation (40%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 50.50 | N/A |
| PEG Ratio (TTM) | 0.44 | N/A |
| P/S Ratio (TTM) | 3.35 | N/A |
| P/B Ratio (TTM) | 1.46 | N/A |
| P/FCF Ratio (TTM) | 31.21 | N/A |
| Price to 5YR AVG Earnings Ratio | -73.45 | N/A |
| Price to 5YR AVG FCF Ratio | -188.97 | N/A |
Profitability (33%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.80% | N/A |
| ROE (TTM) | 2.63% | N/A |
| Net Profit Margin (TTM) | 6.57% | N/A |
| ROIC 5YR AVG | 0.31% | N/A |
Growth (73%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 59.98% | 68.77% | 11.15% |
| Revenue | 16.13% | 26.70% | 11.28% |
| Net Income | 59.62% | 69.62% | 7.76% |
| Cash Flow | 394.22% | -142.03% | -78.20% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.62 | N/A |
| Quick Ratio (TTM) | 2.62 | N/A |
| D/E Ratio (TTM) | 2.03 | N/A |
| Interest Coverage (TTM) | 1.88 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 0.63 | N/A |
| LTL to 5YR AVG FCF | -262.35 | N/A |
| Shares Outstanding Growth 5YR AVG | 3.30% | N/A |